PPA
EDIT icon

Parametric Portfolio Associates’s Editas Medicine EDIT Stock Holding History

Parametric Portfolio Associates’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$706K Sell
37,140
-27,741
-43% -$516K ﹤0.01% 2940
2021
Q4 		$1.72M Sell
64,881
-9,102
-12% -$313K ﹤0.01% 2523
2021
Q3 		$3.04M Buy
73,983
+6,108
+9% +$335K ﹤0.01% 2164
2021
Q2 		$3.84M Sell
67,875
-464
-0.7% -$17.1K ﹤0.01% 2038
2021
Q1 		$2.87M Sell
68,339
-55,644
-45% -$3.17M ﹤0.01% 2549
2020
Q4 		$8.69M Buy
123,983
+67,808
+121% +$2.79M 0.01% 1679
2020
Q3 		$1.58M Buy
56,175
+5,436
+11% +$177K ﹤0.01% 2648
2020
Q2 		$1.5M Buy
50,739
+8,679
+21% +$227K ﹤0.01% 2682
2020
Q1 		$834K Buy
42,060
+6,865
+20% +$173K ﹤0.01% 2894
2019
Q4 		$1.04M Sell
35,195
-6,885
-16% -$172K ﹤0.01% 3043
2019
Q3 		$957K Sell
42,080
-13,211
-24% -$327K ﹤0.01% 3046
2019
Q2 		$1.37M Sell
55,291
-21,677
-28% -$517K ﹤0.01% 2888
2019
Q1 		$1.88M Buy
76,968
+34,229
+80% +$775K ﹤0.01% 2697
2018
Q4 		$972K Buy
42,739
+21,830
+104% +$594K ﹤0.01% 2994
2018
Q3 		$665K Sell
20,909
-2,200
-10% -$71.1K ﹤0.01% 3302
2018
Q2 		$828K Buy
23,109
+8
+0% +$283 ﹤0.01% 3142
2018
Q1 		$766K Buy
23,101
+1,825
+9% +$65K ﹤0.01% 3146
2017
Q4 		$654K Buy
21,276
+35
+0.2% +$881 ﹤0.01% 3207
2017
Q3 		$510K Sell
21,241
-12
-0.1% -$228 ﹤0.01% 3411
2017
Q2 		$357K Buy
+21,253
New +$383K ﹤0.01% 3547

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parametric Portfolio Associates's EDIT Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Editas Medicine (EDIT) stake by 43% in Q1 2022, selling an estimated $516K and leaving 37,140 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

Parametric Portfolio Associates first reported a position in EDIT in Q2 2017 and has held it in 20 quarters since. The position peaked at $8.69M in Q4 2020. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

  • Parametric Portfolio Associates held 37,140 shares of Editas Medicine worth $706K as of Q1 2022.
  • Parametric Portfolio Associates sold 27,741 Editas Medicine shares in Q1 2022, an estimated $516K.
  • Editas Medicine made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2940 holding.
  • Parametric Portfolio Associates first reported a position in Editas Medicine in Q2 2017 and has held it in 20 quarters since.
  • Parametric Portfolio Associates's Editas Medicine position peaked at $8.69M in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.